Decreased expression of PTPN12 correlates with tumor recurrence and poor survival of patients with hepatocellular carcinoma.
第一作者:
Rong-Zhen,Luo
第一单位:
Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou, China ; Department of Pathology, Sun Yat-sen University Cancer Center, Guangzhou, China.
作者:
医学主题词
成年人(Adult);老年人(Aged);癌, 肝细胞(Carcinoma, Hepatocellular);女(雌)性(Female);随访研究(Follow-Up Studies);基因表达调控, 肿瘤(Gene Expression Regulation, Neoplastic);人类(Humans);免疫组织化学(Immunohistochemistry);肝肿瘤(Liver Neoplasms);男(雄)性(Male);中年人(Middle Aged);肿瘤复发, 局部(Neoplasm Recurrence, Local);肿瘤分期(Neoplasm Staging);预后(Prognosis);蛋白质酪氨酸磷酸酶, 非受体12型(Protein Tyrosine Phosphatase, Non-Receptor Type 12);ROC曲线(ROC Curve);肿瘤负荷(Tumor Burden)
DOI
10.1371/journal.pone.0085592
PMID
24475046
发布时间
2021-10-21
- 浏览34
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文


换一批



